QUIPERL Trademark

Trademark Overview


On Monday, March 1, 2021, a trademark application was filed for QUIPERL with the United States Patent and Trademark Office. The USPTO has given the QUIPERL trademark a serial number of 79312655. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, February 26, 2024. This trademark is owned by NOVARTIS AG. The QUIPERL trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
quiperl

General Information


Serial Number79312655
Word MarkQUIPERL
Filing DateMonday, March 1, 2021
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, February 26, 2024
Registration Number6564857
Registration DateTuesday, November 23, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, February 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, June 3, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, June 10, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 15, 2021APPLICATION FILING RECEIPT MAILED
Friday, July 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, July 31, 2021ASSIGNED TO EXAMINER
Wednesday, August 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 18, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 18, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, September 4, 2021NOTIFICATION PROCESSED BY IB
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, December 23, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, March 10, 2022FINAL DISPOSITION PROCESSED
Thursday, March 10, 2022FINAL DISPOSITION NOTICE SENT TO IB
Sunday, April 3, 2022NOTIFICATION PROCESSED BY IB
Friday, September 20, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, September 20, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED